Ignite Creation Date:
2024-07-17 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06469710
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-06-13
Brief Title:
A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients
Sponsor:
RenJi Hospital
Organization:
RenJi Hospital
Study Overview
Official Title:
A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in Patients With Metastatic Prostate Cancer
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to compare the number of CTCs enriched by both sampling methods leukapheresis and collection of peripheral blood in metastatic prostate cancer patients The main questions it aims to answer are
1 The advantages and disadvantages of two sampling methods for further diagnosis and treatment
2 How to obtain further information on the tumour biology of CTC
3 The mechanisms of prostate cancer invasion and metastasis Participants will have 75mL of peripheral blood taken as well as undergo leukapheresis
1 The advantages and disadvantages of two sampling methods for further diagnosis and treatment
2 How to obtain further information on the tumour biology of CTC
3 The mechanisms of prostate cancer invasion and metastasis Participants will have 75mL of peripheral blood taken as well as undergo leukapheresis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None